软骨
细胞生物学
细胞外基质
骨关节炎
炎症
线粒体
软骨细胞
化学
氧化应激
细胞外
颞下颌关节
活性氧
基质金属蛋白酶
病理
药理学
发病机制
滑膜关节
变性(医学)
医学
糖酵解
生物化学
癌症研究
线粒体内膜
小泡
生物
胞外囊泡
组织工程
姜黄素
体外
作者
Weiwen Ge,Lei Qi,Wang Yun,Jing Wang,Xin Fang,Shixue Lei,Dan Lin,Lei Zhang,Shanyong Zhang
标识
DOI:10.1016/j.mtbio.2025.102674
摘要
Temporomandibular joint osteoarthritis (TMJOA) is a degenerative joint disease characterized by progressive degradation of the cartilage matrix. Current clinical interventions mainly offer symptomatic relief but fail to halt disease progression. The pathogenesis of TMJOA is driven by mitochondrial dysfunction, which promotes both chondrocyte inflammation and extracellular matrix breakdown. To address these issues, an integrated therapeutic system was developed by encapsulating curcumin into M2 macrophage-derived extracellular vesicles (Cur@M2-EVs) through ultrasonic processing. In vitro studies demonstrated that Cur@M2-EVs effectively attenuated inflammatory responses and cartilage matrix degradation by scavenging reactive oxygen species (ROS), restoring mitochondrial membrane potential, and shifting cellular metabolism from glycolysis back to oxidative phosphorylation. Furthermore, transcriptomic analysis and experimental validation revealed that Cur@M2-EVs alleviate chondrocyte inflammation primarily by suppressing Thbs1 expression. To enable sustained drug release and enhance joint lubrication, Cur@M2-EVs were further encapsulated within poly (ethylene glycol) diacrylate (PEGDA) hydrogel microspheres, forming the Cur@M2-EVs@PEGDA system. In a monosodium iodoacetate (MIA)-induced rat model of TMJOA, intra-articular injection of Cur@M2-EVs@PEGDA microspheres significantly alleviated cartilage destruction and improved joint lubrication. This study proposes a novel disease-modifying strategy for TMJOA treatment by integrating mitochondrial regulation, immunomodulation, and sustained lubricating release within a single platform, offering a promising therapeutic approach for this challenging condition.
科研通智能强力驱动
Strongly Powered by AbleSci AI